[Low-dose rituximab in IgA-mediated autoimmune hemolytic anemia: a case report and literatures review].

Li, Y; Li, J P; Li, Y; Wang, J Y; Zhou, X L; Mi, Y C; Zhou, K; Peng, G X; Ye, L; Fan, H H; Song, L; Li, P; Li, Q; Zhao, X; Yang, Y; Gao, Q Y; Yang, W R; Jing, L P; Zhang, F K; Zhang, L

Li, Y; Li, J P; Li, Y; Wang, J Y; Zhou, X L; Mi, Y C; Zhou, K; Peng, G X; Ye, L; Fan, H H; Song, L; Li, P; Li, Q; Zhao, X; Yang, Y; Gao, Q Y; Yang, W R; Jing, L P; Zhang, F K; Zhang, L.

Afiliação

Zhang L; Therapeutic Center of Anemia, Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC, Tianjin 300020, China.

Zhonghua Xue Ye Xue Za Zhi ; 39(1): 63-65, 2018 Jan 14.

Article em Zh | MEDLINE | ID: mdl-29551038

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343125
https://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.01.015

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: Zh Ano de publicação: 2018 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343125
https://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.01.015

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: Zh Ano de publicação: 2018 Tipo de documento: Article